Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 2
1(33.3%)
Phase 3
1(33.3%)
3Total
N/A(1)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07519538Active Not Recruiting

Southern Sichuan HIV Cohort Study Protocol

Role: lead

NCT07288749Phase 3Not Yet Recruiting

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Role: collaborator

NCT07109037Not ApplicableCompleted

Clinical Study on the Improvement of Adult Idiopathic Scoliosis by Sling Exercise Therapy Training Combined With Conventional Exercise Therapy

Role: lead

NCT03909217Phase 2Completed

Treating Depression With Transcutaneous Electrical Cranial-auricular Acupoint Stimulation (TECAS).

Role: collaborator

NCT03551041Completed

The Neural Representation of Self in Depression Patients

Role: collaborator

All 5 trials loaded